About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Epilepsy Clinical Trials | 925 Studies Recruiting

Clinical TrialsEpilepsy

Epilepsy Clinical Trials

Browse 925 clinical trials for epilepsy. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 41-60 of 925 trials

TerminatedRepetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of EpilepsyThe purpose of this study is to assess the effects of repetitive transcranial magnetic stimulation (rTMS) as a treatment for Epilepsia Partialis Continua (EPC) or refractory…NCT02560597·Ghent CompletedPediatric Seizure Movement Bed AlarmNocturnal seizure and Sudden unexplained death in epilepsy patients (SUDEP) are major concerns for parents and creates anxiety and poor sleep conditions for many families dealing…NCT01855178·Memphis, Tennessee Not yet recruitingSleep Disruption Pattern - Epilepsy Monitoring UnitEpilepsy affects millions worldwide, with 40% of patients experiencing uncontrolled seizures despite medication.NCT06581133 Active not recruitingRandomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults With Focal SeizuresA multicenter, double-blind, randomized, placebo-controlled clinical trial to evaluate the efficacy and safety of vormatrigine in adults with focal seizures (POWER2)NCT07505004·Miami, Florida and 6 others

Related Searches

Data from ClinicalTrials.govTerms

TerminatedA Two-year Open-label Extension Study of Ganaxolone in Patients With Drug-resistant Partial-onset SeizuresA follow-on, two-year open-label extension study of ganaxolone as add-on therapy in adult patients with drug-resistant partial-onset seizuresNCT02519439·Santa Monica, California and 4 others

WithdrawnTo Evaluate the Effect of Perampanel on Objective and Subjective Sleep in Subjects With Insomnia and Partial Onset SeizuresThis will be a multi-center, randomized, double-blind, placebo-controlled, crossover study to evaluate the effects of 2007/Fycompa (perampanel) on sleep, in subjects with well…NCT02220972

CompletedOpen-Label Extension Study to Assess the Safety and Seizure Frequency Associated With Lacosamide for Primary Generalized Tonic-Clonic Seizures in Subjects With EpilepsyThe purpose is to obtain data on the safety and seizure frequency associated with long-term oral Lacosamide for uncontrolled primary generalized tonic-clonic (PGTC) seizures in…NCT01118962·Phoenix, Arizona and 18 others

CompletedClosed-loop System Using Transcranial Direct Current Stimulation (tDCS) for EpilepsyIn this pilot study, the researchers investigated the feasibility of a closed-loop electroencephalography (EEG) / transcranial direct current stimulation (tDCS) system for…NCT01415362·Boston, Massachusetts

CompletedAtkins Plus KetoCal for Childhood EpilepsyThe modified Atkins diet (MAD) is a relatively new, alternative dietary therapy for intractable childhood and adult epilepsy.NCT00681239·Baltimore, Maryland

CompletedEfficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial EpilepsyThe primary objective was to evaluate the efficacy of eslicarbazepine acetate (ESL) administered once daily at 1200 mg or 800 mg, compared with placebo as adjunctive therapy in…NCT00957372·S. Mamede Do Coronado

CompletedComparing Different Treatments in Reducing Dissociative Seizure OccurrenceThe study will test the hypothesis that Cognitive Behavioural Therapy plus Standardised Medical Care (SMC) will have greater clinical and cost effectiveness than SMC alone in…NCT02325544·Bakewell and 39 others

CompletedPreliminary Testing of a Novel Device to Detect Epileptic SeizuresOfficial statistics report around 1000 deaths due to epilepsy in the UK each year (Hanna et al 2002).NCT02286271·Edinburgh and 1 other

RecruitingReal-world Clinical Response to Cenobamate Early add-on in France, Germany and SpainAim of the study is to better characterize the clinical profile of adjunctive cenobamate by collecting data from the current standard clinical practice in France, Germany, and…NCT06716801·Paris, France

CompletedTreatment Outcomes of ReACT for PNESThis research study is examining the effects of Retraining and Control Therapy (ReACT; an intervention focused on changing behaviors and thoughts) for psychogenic non-epileptic…NCT02801136·Birmingham, Alabama

TerminatedStudy of Predictors of Response to Anti Epilepsy in EpilepsyPharmacoresistant epilepsy remains around 30% despite the development of 25 anti epileptic drugs.NCT02883712·Lille

CompletedFollow-up Study of L059 (Levetiracetam) in Epileptic Patients With Partial Onset Seizures by Open Label MethodThe safety and efficacy of L059 was evaluated in patients who completed "N165 Clinical Trial of L059".NCT00160615

CompletedEvaluation of Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.To determine long-term safety and efficacy of pregabalin in patients with partial seizures.NCT00150293·Deakin, Australian Capital Territory and 82 others

TerminatedA Double-blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥ 16 to 75 Years Old) With Partial Onset SeizuresAntiepileptic drugs (AEDs) are the main treatment for epilepsy; however, only a limited number of AEDs are approved for use as monotherapy.NCT00698581·Phoenix, Arizona and 52 others

RecruitingKetogenic Therapy Effects on Electrical and Metabolic Abnormalities in EpilepsyApproximately a fourth of children with seizures do not respond adequately to available therapy.NCT02216500·Gainesville, Florida

CompletedIntravenous Ganaxolone as Adjunctive Therapy to Treat Subjects With Status EpilepticusThis study will evaluate the effectiveness and safety of an investigational drug, IV ganaxolone, as adjunctive therapy to standard of care to treat subjects with status…NCT03350035·Wilmington, Delaware and 7 others

PreviousPage 3 of 47Next